Pharma-industry-focused AI co. Graph raises $13.3 M led by Insight Venture Partners

Hyderabad- and California (USA)-based pharmaceutical-sector-focused artificial intelligence company Graph AI has raised USD 13.3 million in a Series A funding round led by Insight Venture Partners, with participation from existing investor Bessemer Venture Partners.Founded in 2024 by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar, the firm provides an AI-native platform called Graph Safety, designed to automate adverse drug event monitoring, regulatory submissions, and aggregate safety intelligence for the pharmaceutical and biotech industries. In live deployments, the firm claims to have reduced case processing turnaround time by more than 90%, lowering operating costs by up to 66%.The company plans to use the new funds to accelerate its expansion across the US and Europe.